New York, New York–(Newsfile Corp. – August 23, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sable Offshore Corp. (NYSE: SOC): (1) between May…Read More

You might also be interested in reading MaxCyte, TG Therapeutics sign strategic platform license to advance autoimmune cell therapeutics programs.